|
Volumn 90, Issue 8, 2012, Pages 36-41
|
[The impact of antihypertensive therapy on cerebral hemodynamics in patients with metabolic syndrome].
a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
ENALAPRIL;
INDAPAMIDE;
VERAPAMIL;
ARTICLE;
BIOAVAILABILITY;
BLOOD PRESSURE MONITORING;
BRAIN;
BRAIN CIRCULATION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG COMBINATION;
DRUG EFFECT;
FEMALE;
HUMAN;
HYPERTENSION;
MALE;
METABOLIC SYNDROME X;
METHODOLOGY;
MIDDLE AGED;
PATHOPHYSIOLOGY;
RANDOMIZED CONTROLLED TRIAL;
SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;
TREATMENT OUTCOME;
ANTIHYPERTENSIVE AGENTS;
BIOLOGICAL AVAILABILITY;
BLOOD PRESSURE MONITORING, AMBULATORY;
BRAIN;
CEREBROVASCULAR CIRCULATION;
DRUG THERAPY, COMBINATION;
ENALAPRIL;
FEMALE;
HUMANS;
HYPERTENSION;
INDAPAMIDE;
MALE;
METABOLIC SYNDROME X;
MIDDLE AGED;
TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;
TREATMENT OUTCOME;
VERAPAMIL;
|
EID: 84871894120
PISSN: 00232149
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (0)
|